Page last updated: 2024-08-25

3,4-dihydroxyphenylethanol and chronic COVID syndrome

3,4-dihydroxyphenylethanol has been researched along with chronic COVID syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Anpilogov, K; Bertelli, M; Dautaj, A; Dhuli, K; Fioretti, F; Guda, T; Kallazi, M; Lorusso, L; Michelini, S; Naureen, Z; Nodari, S; Paolacci, S	1

Other Studies

1 other study(ies) available for 3,4-dihydroxyphenylethanol and chronic COVID syndrome

Article	Year
Proposal of a food supplement for the management of post-COVID syndrome. European review for medical and pharmacological sciences, 2021, Volume: 25, Issue:1 Suppl Topics: Acetylcarnitine; Adult; Aged; COVID-19; Dietary Supplements; Fatigue; Female; Gastrointestinal Diseases; Humans; Male; Middle Aged; Phenylethyl Alcohol; Pilot Projects; Post-Acute COVID-19 Syndrome; SARS-CoV-2; Self Report; Surveys and Questionnaires; Vitamins	2021

Article

Year

Proposal of a food supplement for the management of post-COVID syndrome.

European review for medical and pharmacological sciences, 2021, Volume: 25, Issue:1 Suppl

Topics: Acetylcarnitine; Adult; Aged; COVID-19; Dietary Supplements; Fatigue; Female; Gastrointestinal Diseases; Humans; Male; Middle Aged; Phenylethyl Alcohol; Pilot Projects; Post-Acute COVID-19 Syndrome; SARS-CoV-2; Self Report; Surveys and Questionnaires; Vitamins

2021